Timing of ibuprofen use and bone mineral density adaptations to exercise training

Wendy M Kohrt, Daniel W Barry, Rachael E Van Pelt, Catherine M Jankowski, Pamela Wolfe, Robert S Schwartz, Wendy M Kohrt, Daniel W Barry, Rachael E Van Pelt, Catherine M Jankowski, Pamela Wolfe, Robert S Schwartz

Abstract

Prostaglandins (PGs) are essential signaling factors in bone mechanotransduction. In animals, inhibition of the enzyme responsible for PG synthesis (cyclooxygenase) by nonsteroidal anti-inflammatory drugs (NSAIDs) blocks the bone-formation response to loading when administered before, but not immediately after, loading. The aim of this proof-of-concept study was to determine whether the timing of NSAID use influences bone mineral density (BMD) adaptations to exercise in humans. Healthy premenopausal women (n = 73) aged 21 to 40 years completed a supervised 9-month weight-bearing exercise training program. They were randomized to take (1) ibuprofen (400 mg) before exercise, placebo after (IBUP/PLAC), (2) placebo before, ibuprofen after (PLAC/IBUP), or (3) placebo before and after (PLAC/PLAC) exercise. Relative changes in hip and lumbar spine BMD from before to after exercise training were assessed using a Hologic Delphi-W dual-energy X-ray absorptiometry (DXA) instrument. Because this was the first study to evaluate whether ibuprofen use affects skeletal adaptations to exercise, only women who were compliant with exercise were included in the primary analyses (IBUP/PLAC, n = 17; PLAC/PLAC, n = 23; and PLAC/IBUP, n = 14). There was a significant effect of drug treatment, adjusted for baseline BMD, on the BMD response to exercise for regions of the hip (total, p < .001; neck, p = .026; trochanter, p = .040; shaft, p = .019) but not the spine (p = .242). The largest increases in BMD occurred in the group that took ibuprofen after exercise. Total-hip BMD changes averaged -0.2% +/- 1.3%, 0.4% +/- 1.8%, and 2.1% +/- 1.7% in the IBUP/PLAC, PLAC/PLAC, and PLAC/IBUP groups, respectively. This preliminary study suggests that taking NSAIDs after exercise enhances the adaptive response of BMD to exercise, whereas taking NSAIDs before may impair the adaptive response.

(c) 2010 American Society for Bone and Mineral Research.

Figures

Fig. 1
Fig. 1
Changes in fat mass and fat-free mass in response to exercise training. Values are mean ± SE.
Fig. 2
Fig. 2
Relative changes (%) in bone mineral density (BMD) adjusted for baseline BMD in response to exercise training in participants who were compliant with the intervention (top panel) and in all participants who finished the intervention (bottom panel). Values are mean ± SE. *Different from the other groups, p ≤ .01. †Different from the other groups, p ≤ .05.

References

    1. Alam I, Warden SJ, Robling AG, Turner CH. Mechanotransduction in bone does not require a functional cyclooxygenase-2 (COX-2) gene. J Bone Miner Res. 2005;20:438–446.
    1. Bakker AD, Klein-Nulend J, Burger EH. Mechanotransduction in bone cells proceeds via activation of COX-2, but not COX-1. Biochem Biophys Res Commun. 2003;305:677–683.
    1. Bauer DC, Orwoll ES, Fox KM, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11:29–35.
    1. Carbone LD, Tylavsky FA, Cauley JA, et al. Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirimpact of cyclooxygenase selectivity. J Bone Miner Res. 2003;18:1795–1802.
    1. Cheng MZ, Zaman G, Rawlinson SC, Pitsillides AA, Suswillo RF, Lanyon LE. Enhancement by sex hormones of the osteoregulatory effects of mechanical loading and prostaglandins in explants of rat ulnae. J Bone Miner Res. 1997;12:1424–1430.
    1. Chow JW. Role of nitric oxide and prostaglandins in the bone formation response to mechanical loading. Exerc Sport Sci Rev. 2000;28:185–188.
    1. Chow JW, Chambers TJ. Indomethacin has distinct early and late actions on bone formation induced by mechanical stimulation. Am J Physiol. 1994;267:E287–E292.
    1. Chow JW, Fox SW, Lean JM, Chambers TJ. Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res. 1998;13:1039–1044.
    1. Forwood MR. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res. 1996;11:168–1693.
    1. Gregory LS, Kelly WL, Reid RC, Fairlie DP, Forwood MR. Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats. Bone. 2006;39:134–142.
    1. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. The FASEB Journal. 2008;22:383–390.
    1. Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P. Bone mineral density and biomechanical properties of spine and femur of ovariectomized rats treated with naproxen. Bone. 1998;22:509–514.
    1. Kasukawa Y, Miyakoshi N, Srivastava AK, et al. The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo. Tohoku J Exp Med. 2007;211:275–283.
    1. Kimmel DB, Coble T, Lane N. Long-term effect of naproxen on cancellous bone in ovariectomized rats. Bone. 1992;13:167–172.
    1. Kis B, Snipes JA, Busija DW. Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties. J Pharmocol Exp Therapeut. 2005;315:1–7.
    1. Kohrt WM, Ehsani AA, Birge SJ., Jr. Effects of exercise involving predominantly either joint-reaction or ground-reaction forces on bone mineral density in older women. J Bone Miner Res. 1997;12:1253–1261.
    1. Kohrt WM, Ehsani AA, Birge SJ. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program. J Appl Physiol. 1998;84:1506–1512.
    1. Lane N, Coble T, Kimmel DB. Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res. 1990;5:1029–1035.
    1. Lane NE, Bauer DC, Nevitt MC, Pressman AR, Cummings SR. Aspirin and nonsteroidal antiinflammatory drug use in elderly women: effects on a marker of bone resorption. The Study of Osteoporotic Fractures Research Group. J Rheumatol. 1997;24:1132–1136.
    1. Li J, Burr DB, Turner CH. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading. Calcif Tissue Int. 2002;70:320–329.
    1. Li M, Thompson DD, Paralkar VM. Prostaglandin E(2) receptors in bone formation. Int Orthop. 2007;31:767–772.
    1. Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Med. 2001;31:115–144.
    1. Morton DJ, Barrett-Connor E, Schneider DL. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study. J Bone Miner Res. 1998;13:1924–1931.
    1. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65:S147–S151.
    1. Nieman DC, Davis JM, Brown VA, et al. Influence of carbohydrate ingestion on immune changes after 2 h of intensive resistance training. J Appl Physiol. 2004;96:1292–1298.
    1. Paulsen G, Benestad HB, Strom-Gundersen I, Morkrid L, Lappegard KT, Raastad T. Delayed leukocytosis and cytokine response to high-force eccentric exercise. Med Sci Sports Exerc. 2005;37:1877–1883.
    1. Pead MJ, Lanyon LE. Indomethacin modulation of load-related stimulation of new bone formation in vivo. Calcif Tissue Int. 1989;45:34–40.
    1. Raisz LG. Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med. 2001;110(Suppl 3A):43S–45S.
    1. Richards JB, Joseph L, Schwartzman K, Kreiger N, Tenenhouse A, Goltzman D. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2006;17:1410–1419.
    1. Saino H, Matsuyama T, Takada J, Kaku T, Ishii S. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats. J Bone Miner Res. 1997;12:1844–1850.
    1. Shen CL, Yeh JK, Wang X. Short-term supplementation of COX-2 inhibitor suppresses bone turnover in gonad-intact middle-aged male rats. J Bone Miner Metab. 2006;24:461–466.
    1. Sibonga JD, Bell NH, Turner RT. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone. J Bone Miner Res. 1998;13:863–870.
    1. Somjen D, Binderman I, Berger E, Harell A. Bone remodelling induced by physical stress is prostaglandin E2 mediated. Biochim Biophys Acta. 1980;627:91–100.
    1. Thorsen K, Kristoffersson AO, Lerner UH, Lorentzon RP. In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest. 1996;98:2446–2449.
    1. van Staa TP, Leufkens HG, Cooper C. Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone. 2000;27:563–568.
    1. Zaman G, Suswillo RF, Cheng MZ, Tavares IA, Lanyon LE. Early responses to dynamic strain change and prostaglandins in bone-derived cells in culture. J Bone Miner Res. 1997;12:769–777.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe